Clinical trial associate
Lud*** ***** (XX anos)
PhD/Post-doctorate em University of Bern (Switzerland)
University of Bern (Switzerland)
Lisboa
|
Experiência
PhD/Post-doctorate
University of Bern (Switzerland)
set 2013
-
out 2018
• Contributed as a first author of research manuscript for scientific publication (under revision) • Demonstrated ability to critically analyze, synthesize and presente complex scientific information to a broad audience in national and international meetings • Trained and mentored junior members of research team • Worked in a challenging and highly competitive environment • Successfully completed research projects which required multi-tasking, setting priorities, and effective time management
Science Teacher
States schools of Minas Gerais (Brazil)
ago 2009
-
dez 2010
• Planned and instructed Science lessons to middle and high school aged-students • Actively communicated and interacted with other staff members and students of the schools
Scientific Initiation
Federal University of Minas Gerais (Brazil)
fev 2007
-
jul 2009
• Contributed to research projects of Master and PhD students • Worked under supervision on my own project
Laboratory Assistant
Frei Orlando School (Belo Horizonte-Brazil)
mar 2006
-
jan 2007
• Supported Science and Chemistry teachers in the preparation of practical lectures to middle and high school students
Formação
Immunology-PhD
University of Bern (Switzerland)
set 2013
-
out 2018
Immunology-Master
University of Bern (Switzerland)
set 2011
-
ago 2013
Biology
Federal University of Minas Gerais (Brazil)
ago 2005
-
jul 2009
Idiomas
Portuguese - Mother tongue
English - Advanced
Informações Adicionais
Clinical Trials Monitoring Course
Lusófona University, Lisbon, Portugal. (Topics approached during the course: basic concepts of statistics applied in clinical trials; submission of clinical trials documents to INFARMED and CEIC; techniques in monitoring clinical trials (including site feasibility, initiation, monitoring and close out visits training); risk management in clinical trials including serious adverse events notification).
